Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Atherosclerosis

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2013.09.037PMID 24267241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.

  2013influential reference
• Randomized clinical trial of angiotensin‐converting enzyme inhibitor, ramipril, in patients with intermittent claudication

  2013cited by this paper
• Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials.

  2012cited by this paper
• Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials.

  2011cited by this paper
• Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.

  2011cited by this paper
• Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease

  2009cited by this paper
• Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients

  2008cited by this paper
• Peripheral arterial disease: diagnosis and management.

  2008cited by this paper
• Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis

  2008cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Brief Communication: Ramipril Markedly Improves Walking Ability in Patients with Peripheral Arterial Disease

  2006influential reference
• International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.

  2006cited by this paper
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

  2004cited by this paper
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

  2004cited by this paper
• Arterial stiffness: pathophysiology and clinical impact.

  2004cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Systematic Review: Antihypertensive Drug Therapy in Black Patients

  2004cited by this paper
• Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.

  2003cited by this paper
• Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases

  2003cited by this paper
• Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease

  2003cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2002cited by this paper
• The contribution of nitric oxide to exercise hyperemia in the human forearm

  2002cited by this paper
• A comparison of cilostazol and pentoxifylline for treating intermittent claudication.

  2000cited by this paper
• Peripheral arterial disease: insights from population studies of older adults.

  2000cited by this paper
• A clinical approach to the management of the patient with coronary (Co) and/or carotid (Ca) artery disease who presents with leg ischaemia (Lis).

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.

  1999cited by this paper
• A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.

  1999cited by this paper
• Factors involved in the maintenance of endothelial function.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide.

  1996cited by this paper
• Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Exercise Rehabilitation Programs for the Treatment of Claudication Pain: A Meta-analysis

  1995cited by this paper
• Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors.

  1995cited by this paper
• Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

  1995cited by this paper
• ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.

  1994influential reference
• Variance imputation for overviews of clinical trials with continuous response.

  1992cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• The effect of enalapril on leg muscle blood flow in patients with claudication.

  1990cited by this paper
• Assessment of Captopril and Nicardipine Effects on Chronic Occlusive Arterial Disease of the Lower Extremity Using Doppler Ultrasound

  1988cited by this paper
• Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.

  1987cited by this paper
• Letter: Transfer-factor therapy of chronic active hepatitis.

  1974cited by this paper

• Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study

  2025cites this paper
• Impact of guideline-directed medical therapy on 5-year mortality in patients with newly diagnosed peripheral artery disease.

  2023cites this paper
• Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation

  2023cites this paper
• Focus on Prevention: Peripheral Arterial Disease and the Central Role of the Cardiologist

  2023cites this paper
• Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica

  2022cites this paper
• Sex Differences in Peripheral Artery Disease

  2022cites this paper
• Sodium thiosulfate, a source of hydrogen sulfide, stimulates endothelial cell proliferation and neovascularization

  2022cites this paper
• Maximizing the medical support, the first essential complementary treatment - controlling the infection, protecting the heart and the brain

  2021cites this paper
• Vascular Diseases

  2021cites this paper
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

  2021cites this paper
• [Key aspects of drug therapy in vascular surgery].

  2021cites this paper
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

  2021cites this paper
• The Prevention of Cardiovascular Disease in Older Adults

  2020cites this paper
• Improved Survival with Angiotensin Converting Enzyme Inhibitors & Angiotensin Receptor Blockers (ACE/ARB) in Chronic Limb Threatening Ischemia (CLTI).

  2020cites this paper
• Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI/ARB) are Associated with Improved Limb Salvage After Infrapopliteal Interventions for Critical Limb Ischemia.

  2020cites this paper
• Current and emerging drug treatment strategies for peripheral arterial disease

  2020cites this paper
• 1 The process of guideline compilation.

  2019cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

  2019cites this paper
• The position of Polish experts on conservative management in patients with artery diseases of lower limbs

  2019cites this paper
• 5 Conservative treatment for PAD - Risk factor management.

  2019cites this paper
• Konservative Therapie der peripheren arteriellen Verschlusskrankheit

  2019cites this paper
• Stanowisko polskich ekspertów dotyczące leczenia zachowawczego u pacjentów z chorobą tętnic kończyn dolnych

  2019cites this paper
• 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b

  2018cites this paper
• Medical and lifestyle management of peripheral arterial disease.

  2018cites this paper
• Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS)

  2018cites this paper
• PAVK der unteren Extremitäten – konservative und antithrombotische Therapie

  2018influential citation
• Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

  2018cites this paper
• Nitric oxide donors for peripheral artery disease

  2018cites this paper
• Artérite des membres inférieurs

  2017cites this paper
• Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases , in collaboration with the European Society for Vascular Surgery ( ESVS ) – Web Addenda

  2017cites this paper
• Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials

  2017cites this paper
• German guideline on the diagnosis and treatment of peripheral artery disease - a comprehensive update 2016.

  2017cites this paper
• Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention.

  2017cites this paper
• Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes.

  2016cites this paper
• Allopurinol in Vascular Disease: Is There a New Role for an Old Drug?

  2016cites this paper
• Vascular disease in the older adult

  2016cites this paper
• Angiotensin converting enzyme inhibitors and walking distance: Have we walked the whole distance?

  2016cites this paper
• Novel method to assess arterial insufficiency in rodent hind limb.

  2016cites this paper
• The Diagnosis and Treatment of Peripheral Arterial Vascular Disease.

  2016cites this paper
• peripheral artery disease Pharmacological Treatment and Current Management of Peripheral Artery Disease

  2015cites this paper
• Clinical effectiveness of the angiotensin converting enzyme inhibitor, Ramipril, in patients with intermittent claudication: Randomised, double-blind, placebo-controlled trial

  2015cites this paper
• Pharmacological treatment and current management of peripheral artery disease.

  2015cites this paper
• Peripheral Arterial Disease in Hemodialysed Patients

  2015cites this paper
• Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics

  2015cites this paper
• Pharmacology in Peripheral Arterial Disease: What the Interventional Radiologist Needs to Know

  2014cites this paper
• Symptoms of peripheral arterial disease: ramipril

  year unknowninfluential citation